<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">
 <italic>Aedes albopictus</italic> (
 <italic>Stegomyia albopicta</italic>) Skuse, a mosquito native to the tropical and subtropical areas of south and east Asia, is an epidemiologically important vector of numerous viral pathogens, including yellow, dengue, chikungunya, and potentially Zika fever viruses [
 <xref ref-type="bibr" rid="CR1">1</xref>–
 <xref ref-type="bibr" rid="CR4">4</xref>]. An aggressive invasive species, 
 <italic>Ae. albopictus</italic> has invaded and adapted to diverse environments in numerous countries across all continents except Antarctica [
 <xref ref-type="bibr" rid="CR5">5</xref>]. The frequent outbreaks of dengue and chikungunya fevers in southern and southeastern China over the past few decades, and in central and eastern China in the past few years have raised major public health concerns [
 <xref ref-type="bibr" rid="CR6">6</xref>–
 <xref ref-type="bibr" rid="CR8">8</xref>]. In numerous cases, 
 <italic>Ae. albopictus</italic> has been the sole vector responsible for dengue fever outbreaks in China [
 <xref ref-type="bibr" rid="CR8">8</xref>, 
 <xref ref-type="bibr" rid="CR9">9</xref>]. At present, vaccines are available for some 
 <italic>Aedes</italic> mosquito transmitted diseases such as yellow fever and dengue fever. However, Sanofi Pasteur, the dengue fever vaccine manufacturer, announced in 2017 that people who receive the vaccine and have not been infected previously with a dengue virus may be at risk of developing severe dengue fever if they contract dengue after being vaccinated (
 <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/dengue/prevention/dengue-vaccine.html" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.cdc.gov/dengue/prevention/dengue-vaccine.html</ext-link>).
</p>
